// App-Quantinova.ai

: Proton-pump inhibitors (PPIs) and survival outcomes in patients with metastatic renal cell carcinoma (mRCC).

Researchers

Presenter

  • Aly-Khan A. Lalani

Principal Investigators

  • Rana R. McKay

  • Xun Lin

  • Ronit Simantov

  • Marina D. Kaymakcalan

  • Toni K. Choueiri

Medical Centers

  • Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada

  • Dana-Farber Cancer Institute, Boston, MA

  • Pfizer Inc, San Diego, CA

  • Pfizer Inc, New York, NY

Locations

  • Canada

  • United States

Companies

  • PharmAbcine Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved